Optics and Spectroscopy is a pivotal peer-reviewed journal published by Pleiades Publishing Inc, focusing on the intricate fields of atomic and molecular physics, as well as optics. Established in 1972, and enjoying a legacy of convergence periods that reinforce its commitment to the evolving landscape of these scientific domains, the journal aims to disseminate high-quality research that advances our understanding of light-matter interactions, electronic materials, and spectroscopic techniques. Despite its current Q4 categorization in both the Atomic and Molecular Physics and Electronic, Optical and Magnetic Materials fields, with corresponding Scopus rankings reflecting its developing influence, the journal remains a valuable resource for researchers and professionals seeking to publish their findings, explore new methodologies, and connect with a community dedicated to innovation in optics. Although there is currently no open access option, the journal's expansive readership and its stability in publication over the decades make it an important platform for both established and emerging researchers in the field.

MOLECULAR CANCER THERAPEUTICS, published by the American Association for Cancer Research, is a premier journal dedicated to advancing the field of cancer research and therapy since 2001. With a notable impact factor reflecting its high-quality content, this journal stands out in the Q1 category for both Cancer Research and Oncology as of 2023. Researchers, clinicians, and students interested in innovative treatment strategies and molecular mechanisms can find valuable insights within its pages, bolstered by a rigorous peer-review process and a global perspective on cancer therapeutic developments. Although the journal operates under a subscription model, it provides comprehensive access to cutting-edge studies and reviews that drive forward the understanding of cancer biology and treatment modalities. The journal's impressive Scopus rankings further validate its influence within both oncology and the broader cancer research community, making it an indispensable resource for anyone committed to combating cancer through science.

Oncology in Clinical Practice is a vital resource in the field of oncology, published by VIA MEDICA in Poland. This peer-reviewed journal, with ISSN 2450-1654 and E-ISSN 2450-6478, aims to bridge the gap between clinical practice and cancer research, providing a platform for the dissemination of original research, reviews, and case studies. Since its inception in 2019, the journal has featured significant contributions to the understanding of cancer treatment and patient care, although it currently holds a Q4 ranking in Oncology with a Scopus rank of #313/404 and a 22nd percentile in the Medicine _ Oncology category. Though it is not an open-access journal, its content is invaluable for oncologists, researchers, and students, offering critical insights and advancements in clinical approaches to cancer management. With a commitment to enhancing patient outcomes through clinical evidence, Oncology in Clinical Practice serves as an essential reference for those dedicated to the fight against cancer.

JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY is a prestigious academic journal published by Elsevier Science SA in the Netherlands, focusing on the interdisciplinary domains of photochemistry and photobiology. With a notable impact factor and distinguished recognition across multiple disciplines, including Q1 rankings in Biophysics, Radiation, and Radiological and Ultrasound Technology, this journal is at the forefront of research dissemination in its field. The publication spans over three decades, from 1987 to 2024, reflecting its long-standing commitment to advancing knowledge in areas critical to both fundamental and applied science. Researchers and professionals are encouraged to submit original research articles, reviews, and short communications that explore the interactions between light and biological systems, with the aim of fostering innovative solutions impacting health and technology. Although it operates on a subscription model, this journal remains a vital resource for all those engaged in the scientific exploration of these dynamic fields.

Radiation Oncology is a premier scholarly journal published by BMC, dedicated to advancing the field of oncology through innovative research and comprehensive reviews since its inception in 2005. With its Open Access model, the journal ensures that the latest findings in radiotherapy and cancer treatment are accessible to a global audience, fostering collaboration and knowledge sharing among researchers, clinicians, and healthcare professionals. The journal has garnered an impressive reputation with prestigious rankings, achieving Q1 status in Radiology, Nuclear Medicine and Imaging and Q2 in Oncology as of 2023, reflecting its significant impact on the scientific community. In the Scopus rankings, it stands proud at Rank #61 in Radiology, Nuclear Medicine and Imaging, placing it in the top 81st percentile, and Rank #112 in Oncology at the 72nd percentile. With a converged publication plan extending through 2024, Radiation Oncology remains a vital resource for those dedicated to enhancing cancer treatment methodologies and outcomes.

Advanced Therapeutics, published by WILEY in the United Kingdom, stands at the forefront of medical and pharmaceutical research, offering invaluable insights from 2018 to 2024. This distinguished journal, with an E-ISSN of 2366-3987, is recognized for its exceptional academic rigor, boasting an impressive array of Q1 categorizations in essential fields such as Biochemistry (medical), Pharmaceutical Science, and Pharmacology. With its strategic focus on interdisciplinary studies and cutting-edge therapeutic developments, Advanced Therapeutics serves as a vital resource for researchers, professionals, and students keen on advancing their knowledge and contributing to the evolving landscape of medicine and genetics. The journal's high Scopus rankings further affirm its impact, with significant placements in multiple categories underscoring the quality of published research. Although the journal operates under a subscription model, its accessibility to high-impact findings ensures that it remains a pivotal platform for innovative discourse in therapeutics.

PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES is a distinguished peer-reviewed journal published by SpringerNature, focusing on the rigorous exploration of photochemical and photobiological processes that impact various scientific disciplines. Established in 2002, this journal serves as a vital resource for researchers and professionals in the fields of chemistry, biology, and environmental sciences, addressing fundamental questions as well as practical applications. With an impressive Scopus ranking of #67 out of 189 in the category of Physical and Theoretical Chemistry, it holds a significant position within the academic community, evidenced by its Q2 quartile ranking in 2023. Although it operates under a subscription model, the journal encourages broad engagement from scholars by hosting various articles that contribute to the understanding of light-mediated chemical processes and their relevance to ecological and biological phenomena. The journal’s objectives include fostering innovative research, supporting interdisciplinary collaboration, and disseminating knowledge that drives advancements in both academic and applied sciences. By bridging theoretical insights with practical applications, PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES continues to make substantial contributions to the scientific discourse surrounding photochemistry and photobiology.

Cancer Treatment Reviews, published by Elsevier Science Ltd, is a leading international journal dedicated to the exploration and advancement of therapeutic strategies in oncology. With an impressive impact factor that reflects its status in the field, this journal is classified within Q1 quartile rankings in Medicine (Miscellaneous), Oncology, and Radiology, Nuclear Medicine and Imaging, as of 2023. The journal has a rich lineage, having been established in 1974 and consistently evolving to encompass the latest breakthroughs and methodologies in cancer treatment. A vital resource for researchers, clinicians, and students alike, it aims to promote understanding and application of effective interventions, thereby contributing to improvements in patient outcomes. By prioritizing high-quality reviews, Cancer Treatment Reviews plays an essential role in bridging the gap between current research and clinical practice, making it an indispensable asset in the continuous fight against cancer.

Advances in Urology is a premier scholarly journal published by HINDAWI LTD that has been contributing to the field of urology and obstetrics since its establishment. With an impact factor reflecting its growing influence, this Open Access journal, available since 2008, ensures that researchers and professionals can readily access cutting-edge developments in urological health, surgical techniques, and innovative treatment methodologies. Based in the United States, the journal covers a wide array of topics relevant to urology and obstetrics, maintaining a notable presence in academic rankings, with a Q2 category designation in both fields as of 2023. The journal is indexed in Scopus, ranking #54 out of 120 in Urology and #95 out of 209 in Obstetrics and Gynecology, further adding to its credibility and reach. As it converges from 2009 to 2024, Advances in Urology continues to be a vital resource for researchers, professionals, and students seeking to stay abreast of significant advancements and discussions within these critical areas of medicine.

Dermatologic Therapy is a leading peer-reviewed journal published by WILEY-HINDAWI that focuses on the multifaceted field of dermatology. Established in 1996 and continuing its profound impact into 2024, the journal has earned an impressive Q1 rating in Dermatology and ranks 11th out of 142 in the Scopus categorization, placing it in the 92nd percentile. With its headquarters in the United Kingdom, the journal's mission is to advance the understanding and treatment of skin diseases through the dissemination of high-quality research, reviews, and clinical information. Although not an open-access journal, it provides extensive access options to ensure that vital research reaches its audience. By leading scholarly discourse and innovation in dermatological treatments, Dermatologic Therapy serves as an essential resource for researchers, clinicians, and students dedicated to improving skin health worldwide.